Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$466M |
| 2 |
Applovin
APP
|
+$349M |
| 3 |
General Dynamics
GD
|
+$272M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$257M |
| 5 |
iShares Global Infrastructure ETF
IGF
|
+$222M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ANSS
Ansys
ANSS
|
+$396M |
| 2 |
HES
Hess
HES
|
+$383M |
| 3 |
Apple
AAPL
|
+$362M |
| 4 |
NVIDIA
NVDA
|
+$298M |
| 5 |
Microsoft
MSFT
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.46% |
| 2 | Financials | 12.23% |
| 3 | Consumer Discretionary | 9.45% |
| 4 | Communication Services | 8.8% |
| 5 | Healthcare | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Integra LifeSciences
IART
$1.29B
| $11.7M | ﹤0.01% |
814,339
+71,180
| +10% | +$975K |
|
2027
Biohaven
BHVN
$2.03B
| $11.6M | ﹤0.01% |
775,895
-600
| -0.1% | -$8.73K |
|
|
AIV
2028
Aimco
AIV
$387M
| $11.6M | ﹤0.01% |
1,467,800
-28,079
| -2% | -$228K |
|
2029
NovoCure
NVCR
$1.73B
| $11.6M | ﹤0.01% |
897,120
-238,340
| -21% | -$3.18M |
|
2030
Coty
COTY
$2.42B
| $11.6M | ﹤0.01% |
2,865,003
-57,611
| -2% | -$264K |
|
2031
NeoGenomics
NEO
$1.96B
| $11.5M | ﹤0.01% |
1,489,681
+11,916
| +0.8% | +$83.5K |
|
2032
First Advantage
FA
$3.4B
| $11.5M | ﹤0.01% |
746,101
+51,880
| +7% | +$860K |
|
|
VMEO
2033
DELISTED
Vimeo
VMEO
| $11.5M | ﹤0.01% |
1,480,068
-66,714
| -4% | -$328K |
|
2034
Stepan Co
SCL
$1.46B
| $11.5M | ﹤0.01% |
240,153
-5,461
| -2% | -$283K |
|
|
MRC
2035
DELISTED
MRC Global
MRC
| $11.4M | ﹤0.01% |
793,479
-1,521
| -0.2% | -$21.7K |
|
2036
AMC Entertainment Holdings
AMC
$2.52B
| $11.4M | ﹤0.01% |
3,944,039
+119,030
| +3% | +$353K |
|
|
PMT
2037
PennyMac Mortgage Investment
PMT
$822M
| $11.4M | ﹤0.01% |
931,349
-143,060
| -13% | -$1.77M |
|
2038
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.1B
| $11.4M | ﹤0.01% |
38,228
+1,063
| +3% | +$307K |
|
2039
Atlas Energy Solutions
AESI
$1.35B
| $11.4M | ﹤0.01% |
1,000,623
-49,208
| -5% | -$603K |
|
2040
Worthington Steel
WS
$1.83B
| $11.4M | ﹤0.01% |
373,566
-10,645
| -3% | -$340K |
|
|
SEZL
2041
Sezzle
SEZL
$5.2B
| $11.3M | ﹤0.01% |
142,709
+9,898
| +7% | +$1.14M |
|
2042
Apogee Therapeutics
APGE
$10.1B
| $11.3M | ﹤0.01% |
284,483
+20,295
| +8% | +$775K |
|
2043
Summit Therapeutics
SMMT
$10.4B
| $11.3M | ﹤0.01% |
546,262
+14,634
| +3% | +$355K |
|
2044
Pearson
PSO
$10.2B
| $11.3M | ﹤0.01% |
796,865
+16,496
| +2% | +$237K |
|
2045
Teekay Tankers
TNK
$2.75B
| $11.2M | ﹤0.01% |
221,781
-4,600
| -2% | -$218K |
|
2046
Amylyx Pharmaceuticals
AMLX
$2.26B
| $11.2M | ﹤0.01% |
822,237
+2,073
| +0.3% | +$19.5K |
|
|
NPKI
2047
NPK International
NPKI
$1.06B
| $11.2M | ﹤0.01% |
987,985
-2,007
| -0.2% | -$19.6K |
|
2048
LegalZoom.com
LZ
$1.35B
| $11.2M | ﹤0.01% |
1,076,084
+64,667
| +6% | +$645K |
|
2049
Helix Energy Solutions
HLX
$1.4B
| $11.2M | ﹤0.01% |
1,699,861
-43,927
| -3% | -$276K |
|
2050
AdaptHealth
AHCO
$1.47B
| $11.1M | ﹤0.01% |
1,245,416
+151,255
| +14% | +$1.4M |
|
Similar funds
Northern Trust's Q3 2025 Portfolio in Review
As of Q3 2025, Northern Trust held 4,566 positions worth $782B, up 7.5% from $727B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Northern Trust's Q3 2025 filing shows 167 new, 1,770 increased, 2,268 reduced and 144 closed positions. Its largest new stake was Amrize Ltd: 1,020,799 shares worth $49.5M. The largest sale was Ansys, an estimated $396M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
- Northern Trust's largest Q3 2025 buy was Amrize Ltd: 1,020,799 shares worth $49.5M.
- Northern Trust added most to Chevron in Q3 2025, an estimated $466M increase.
- Northern Trust's biggest Q3 2025 reduction was Apple, cutting an estimated $362M.
- Northern Trust fully exited Ansys in Q3 2025, selling an estimated $396M.
- Northern Trust's ten largest holdings make up 30% of its $782B portfolio in Q3 2025.
- Northern Trust opened 167 new positions and closed 144 in Q3 2025.
- Northern Trust's portfolio value rose 7.5% quarter-over-quarter to $782B.
Based on Northern Trust's 13F filing for Q3 2025, filed 14 Nov 2025.